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Two clinical isolates of Mycoplasma hyosynoviae showed
differing pattern of lameness and pathogen detection in
experimentally challenged pigs
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Mycoplasma (M.) hyosynoviae is known to colonize and cause disease in growing-finishing pigs. In this study, two clinical isolates of M.
hyosynoviae were compared by inoculating cesarean-derived colostrum-deprived and specific-pathogen-free growing pigs. After intranasal
or intravenous inoculation, the proportion and distribution pattern of clinical cases was compared in addition to the severity of lameness.
Tonsils were found to be the primary site of colonization, while bacteremia was rarely detected prior to the observation of clinical signs.
Regardless of the clinical isolate, route of inoculation, or volume of inocula, histopathological alterations and tissue invasion were detected
in multiple joints, indicating an apparent lack of specific joint tropism. Acute disease was primarily observed 7 to 10 days post-inoculation.
The variability in the severity of synovial microscopic lesions and pathogen detection in joint cavities suggests that the duration of joint
infection may influence the diagnostic accuracy. In summary, these findings demonstrate that diagnosis of M. hyosynoviae-associated arthritis
can be influenced by the clinical isolate, and provides a study platform to investigate the colonization and virulence potential of field isolates.
This approach can be particularly relevant to auxiliate in surveillance and testing of therapeutic and/or vaccine candidates.
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Introduction
Mycoplasma (M.) hyosynoviae is known for causing nonpurulent arthritis in growing pigs [16,22], and its ubiquitous
nature in pig populations [11,22]. Pigs of all ages are believed to
be susceptible to colonization [10,12]. Sows are presumably the
primary infectious reservoir, and piglets can become colonized
prior to weaning, or by horizontal transmission post-weaning
[8,17]. Upon colonization, M. hyosynoviae can persist in the
tonsils and animals may become life-long carriers [2,17].
Bacteremia occurs in a subset of susceptible pigs, and has been
shown to precede clinical disease [7]. Although the disease risk
factors are not fully understood, M. hyosynoviae-associated
arthritis is often reported to occur upon exposure to environmental
stressors such as temperature fluctuation, increased stocking

density, and commingling of non-litter mates [15]. However,
the virulence determinants and host pathways that converge to
the occurrence of the disease phenotype typically seen in field
cases are still not understood [1,11]. Although M. hyosynoviaeassociated disease has been experimentally reproduced before
[7,12,18], this study was conducted to determine if distinct
clinical isolates could have different disease phenotypes, and
which inoculation route and infectious dose combination would
be more robust to reproduce them. Additionally, multiple
diagnostic specimens were tested for the presence of M.
hyosynoviae and induced histological alterations to determine
the optimal criteria for clinical diagnosis.
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Materials and Methods
Two clinical isolates obtained from temporally, spatially, and
herd-source differing field cases (diagnosed by the Iowa State
University Veterinary Diagnostic Laboratory; ISU-VDL) of pig
M. hyosynoviae-associated arthritis (i.e., 3491 and 3496) were
used to challenge pigs intranasally (IN) or intravenously (IV).
Pigs inoculated IN with isolate 3491 received either 5 mL (n =
5 per group) or 10 mL (n = 5 per group), while all pigs inoculated
IN with isolate 3496 received 10 mL (n = 5 per group). Animals
inoculated IV received 2 mL of either 3491 (n = 11) or 3496
(n = 7). Control animals (n = 4) received the same medium used
to grow this bacterium either IN (n = 3) or IV (n = 1). For this
study, six to twelve week old cesarean-derived colostrum-deprived
(CDCD) specific-pathogen-free (SPF) pigs were acquired from
a herd known to be free of all major swine mycoplasmas
including, M. hyopneumoniae, M. hyosynoviae, M. hyorhinis,
and M. flocculare, as determined by serology and species-specific
conventional or quantitative polymerase chain reaction assays
(qPCR) of nasal swab and tonsil scraping fluid samples from all
experimental animals [3,5,21]. The pigs were housed in a
BSL-2 facility at the ISU-VDL and all husbandry procedures
were carried out following routine SPF facility biosecurity
protocols to prevent cross-contamination. Pigs were fed
commercial feed with no antibiotics (Nature’s Made;
Heartland, USA). Prior to M. hyosynoviae inoculation, all pigs
were treated intramuscularly with 2 mL of ceftiofur sodium
(Excede; Zoetis, USA) to prevent post-arrival infection with
any other bacteria. All animal experimental protocols were
approved by Iowa State University’s Institutional Care and Use
Committee.
Inoculum preparation and animal inoculation
Culture of M. hyosynoviae was carried out using previously
described protocols [18,20]. The two clinical isolates used
herein were isolated from clinical specimens known to be
devoid of any other major swine bacterial and viral pathogens
by the ISU-VDL (i.e., Haemophilus parasuis, Streptococcus
suis, M. hyorhinis, Salmonella spp., Erysipelothrix rhusiopathiae,
Porcine circovirus, and Porcine reproductive and respiratory
syndrome virus). For isolation, a 1 : 10 ratio of filtered joint
fluids from selected clinical specimens were inoculated into
Difco pleuropneumonia like organism (PPLO) (Difco; BD
Biosciences, USA) based media with turkey serum (15%) and
mucin from porcine stomach (5%) broth and incubated at 37oC
for 3 to 7 days. After the initial culture, an aliquot of culture
fluid was tested for the presence of M. hyosynoviae by qPCR
[3]. To confirm the absence of contaminating bacteria, routine
aerobic culture for non-mycoplasma species was also performed
using both chocolate agar and blood agar plates. To develop
challenge material, 1 mL of frozen stock of each isolate was
adapted to Difco PPLO media supplemented with 15%
Journal of Veterinary Science

heat-inactivated horse serum (Donor Horse Serum; Atlanta
Biologicals, USA), termed Difco horse sera (DHS). All sera
utilized throughout the study were heat inactivated at 56oC (via
water bath) for 30 min prior to use. Media was mixed and pH
adjusted to 7.4 (via 1N HCl or 1N NaOH) before being 0.22 m
filtered and placed at 37oC for 48 h to check for contamination
by visual inspection for turbidity. Each media was then
aliquoted into 1.8 mL in 30 tubes to set up a ten-fold serial
dilution series in triplicate. Frozen stock M. hyosynoviae
cultures at passage 2 (p2), 3491 and 3496, were thawed at room
temperature, after which 0.5 mL was used to inoculate 5 mL of
D-TS. Prior to DHS inoculation, Difco Turkey Serum was used
for the initial passage to ensure growth from frozen stock.
Following 24 h of incubation at 37oC, 0.2 mL of p3 were serially
diluted into DHS and incubated. The challenge inocula were
prepared in Difco PPLO media supplemented with 15%
heat-inactivated horse serum (Donor Horse Serum; Atlanta
Biologicals) to prevent anaphylaxis. To prepare challenge
material, 1 mL of each DHS-adapted isolate was passed into 5
mL of fresh DHS, after which a final inoculum was passed into
25 mL of media for challenge administration. A 100 L (10−1
dilution) sample was subsequently spread plated onto blood and
chocolate agar plates for purity verification. Next, 10 L (10−2
dilution) was plated onto brain heart infusion (BHI) agar plates
to confirm mycoplasma growth by morphology. All plating was
performed in triplicate throughout the experiment. Quantification
of all inocula, as per color-changing unit-CCU per mL, was
performed by dilution plating on DHS agar plates and
inoculating broth [20]. Color-changing units per mL were
calculated using arginine and phenol red, and a total of 1010
CCU per mL was used for IV and IN inoculation upon restraining
all animals as previously described [7,20]. For inoculation,
animals were restrained with a snare as previously described
[10]. Despite the route and volume of inoculum administered, a
1010 CCU per mL of either isolate was used. IV inoculation was
carried out using a butterfly catheter in an ear vein; whereas, for
IN administration half of the inoculum was placed into each
nostril using a sterile syringe [7,18].
Clinical observations and in vivo sampling
Pigs were clinically monitored prior to and after inoculation
for any clinical signs, particularly lameness. A single evaluator
collected all observations throughout the study to ensure
consistency. Lameness was scored from 0 to 3 (from slightly to
severe clinical signs) as previously described [12]. Whole
blood, nasal swabs, and tonsil scraping samples were collected
prior to inoculation, and every 2 to 3 days post-inoculation (dpi)
until necropsy. A fraction of all blood samples was then
centrifuged at 2,000 × g for 10 min, after which serum was
aliquoted into 5 mL tubes (BD Falcon; BD Biosciences, USA).
Whole blood was collected using a 10 mL EDTA (K2) tube (BD
Vacutainer; BD Diagnostics, USA). Nasal swabs were collected
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using a single 15 cm sterile nylon flocked swab (Puritan;
Puritan Medical Products, USA) sampling both nares each
time, and placed into 5 mL polystyrene round bottom snap-cap
tubes (BD Falcon; BD Biosciences) containing 2 mL of 1×
sterile phosphate buffer saline solution (PBS; Invitrogen,
USA). Tonsil scrapings were collected by holding the mouth
open with a sterilized oral speculum and scraping the surface of
the tonsil using a sterilized, blunt stainless steel spoon with an
elongated handle [23]. Tonsil scraping contents were then
collected from the steel spoon using a 15 cm sterile nylon swab
(Puritan; Puritan Medical Products) and placed into 5 mL tubes
(BD Falcon; BD Biosciences) containing 3 mL of sterile 1×
o
PBS. All samples were stored at −20 C until assayed.
DNA extraction and quantitative PCR
DNA extraction was performed using magnetic beads
(MagMAX Total Nucleic Acid Isolation Kit; Applied
Biosystems, USA) in a semi-automatic system (KingFisher 96
Magnetic Particle Processor; Thermo Fisher Scientific, USA)
according to the manufacturer’s instructions, after which
samples were frozen at −20oC until assayed for M. hyosynoviae
by qPCR [3]. All clinical specimens including nasal swab,
whole blood, serum, tonsil scraping, and synovial fluids or
swabs were tested in duplicate for M. hyosynoviae by qPCR
[3,5,19]. qPCR was also used to detect the presence (1) or
absence (0), and to determine the M. hyosynoviae load per 2.5
L of blood, serum, and joint samples [3].
Necropsy and histopathology
Euthanasia was performed by administering a barbiturate
overdose (Fatal-Plus; Vortech Pharmaceuticals, USA) via IV
injection. At 12, 14 or 15 dpi, animals were necropsied, and the
following joint cavities were sampled: scapula-humeral,
humero-radial, coxi-femoral, femoro-tibial, and tibio-tarsal
from the right and left side of each animal. Joint fluids or swabs
were aseptically collected for M. hyosynoviae qPCR. Synovium
tissues were placed into a 10% buffered formalin solution for
histopathology evaluation. In addition, tonsil tissues were
collected and ground in 10 mL of 1× PBS for M. hyosynoviae
qPCR detection. Joint fluids were also plated on blood agar,
chocolate agar, and BHI, and were cultivated aerobically at
37oC for 3 to 5 days to check for extraneous bacterial growth.
The histopathology scoring used was modified from a
previously described method [6]. Histopathology scores for
each sample were combined to provide a composite inflammatory
score ranging from 0 to 15. Scoring was conducted by a board
certified veterinary pathologist who was blinded to all
treatments.
Statistical analysis
Statistical analysis of the data was performed using the
GraphPad Prism 6 (GraphPad Software, USA) and MedCalc
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15.6 (MedCalc Software, Belgium). Descriptive analysis was
initially conducted to assess the overall quality of the data. The
proportion of clinical cases, degree of lameness cases, and
qPCR positive joints per group, were analyzed using a
Chi-squared test (GraphPad Prism 6). One-way ANOVA was
used to compare the percentage of clinical cases across
treatments over time. Histopathology scoring was analyzed
using a non-parametric one-way ANOVA (Kruskal-Wallis)
followed by multiple group comparison using Dunn’s test. The
significant level across all analyses was based on a p ＜ 0.05.
Receiving operating characteristic curve analysis was used to
determine the cut-off point for the histopathology score to
differentiate diseased vs. non-diseased animals using MedCalc
15.6. After establishing the cut-off, the histopathology results
were converted to a binary variable, with 0 indicating joints
below the threshold histopathology score threshold of 1, and 1
indicating all other values. It should be noted that the binary
value of 1 is different than the histological score of 1. It simply
happens that the threshold established for the microscopic
alteration equals 1. This was justified based on the microscopic
score of 0 for all joints in the control group and the score of 1 in
the disease group being a morphological alteration typically
found in M. hyosynoviae infected animals (i.e., synovial cell
proliferation). The qPCR test results were also interpreted as
negative (0) or positive (1) [3]. The combination of both metrics
(i.e., histopathology and qPCR) was then used to verify the odds
ratio-OR to predict clinical disease. The OR was subsequently
analyzed using a 95% confidence interval, which implies that if
the value of 1 is included in this interval, there is absence of
difference for disease vs. no disease occurrence given this
diagnostic criterion.

Results
Clinical findings
All pigs used in the study were clinically healthy prior to
challenge. Anaphylaxis did not occur upon inoculation.
Lameness was clinically evident post challenge; however, it
varied in severity in pigs from each inoculation group,
regardless of isolate, volume, or route of inoculation (Fig. 1).
Overall, a higher proportion of cases was observed in animals
inoculated with isolate 3491 vs. 3496, with disease developing
more rapidly upon IV inoculation. IN inoculation also led to
robustness in the development clinical disease when using 10
mL of inocula. A significantly higher proportion of cases and
longer duration of lameness were observed for isolate 3491 vs.
3496. Due to limited availability of CDCD-SPF pigs, the 5 mL
volume for IN was only assessed for isolate 3491. A significantly
higher mean lameness score was observed for animals
inoculated IN with 10 mL of isolate 3491 compared to 5 mL,
and this was greater than IV administration (Fig. 2). Overall,
only mild lameness was observed for isolate 3496, despite the
www.vetsci.org
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Fig. 1. Distribution of experimentally induced Mycoplasma (M.)
hyosynoviae- associated clinical cases. Clinical observations
were collected daily from 0 to necropsy across all groups. A
Chi-squared test was used to compare the distribution of clinical
cases (p ＜ 0.05). Overall, a higher percentage of cases was seen
in animals inoculated with isolate 3491 than 3496. The
intravenous (IV) route led to a more rapid development of
clinical signs compared to intranasal (IN) injection. Moreover, IV
and 10 mL inoculation with isolate 3491 led to longer duration
of clinical disease than 3496 (p ＜ 0.05). The results for the
negative control group are not depicted above since there was a
complete absence of clinical cases for those animals.

Fig. 3. Percentage of quantitative polymerase chain reaction
assays (qPCR) positive joints for M. hyosynoviae by isolate,
individually or combined. Overall, a higher percentage of qPCR
positive samples was found in all cases for two anatomical
locations: the humero-radial and coxi-femoral joint. However, a
broad distribution of this pathogen is seen given that at least 30%
of any given joint sample tested positive for the organism. The
control group was not included here since none of the joint
samples in that group tested positive for M. hyosynoviae by
qPCR.

Fig. 2. Mean lameness score (mean + SEM) across M. hyosynoviae
inoculated groups. All observations were taken daily from 0 to
necropsy. The clinical lameness scoring system varied from 0 to
3 corresponding to no lameness, slight, moderate, or severe
clinical signs. The Chi-squared and the Friedman’s tests were
used to compare the distribution of severity of cases across
groups (p ＜ 0.05). A significantly higher mean lameness score
was observed for animals inoculated IN with 10 mL of isolate
3491 than for all other groups between 10 to 14 (p ＜ 0.05).
Results for the negative control group are not shown because of
the lack of clinical lameness for those animals.

Fig. 4. Distribution of the percentage of M. hyosynoviae qPCR
positive joints by isolate and anatomical location. Significant
differences in the proportion of M. hyosynoviae tested positive
joints were found when comparing across inoculated groups by
anatomical location. Asterisks mark the inoculated groups
(isolate and/or volume of inocula) that differ significantly for each
joint cavity (p ＜ 0.05). A higher percentage of M. hyosynoviae
positive joints was found for the following groups: 5 mL IN 3491,
10 mL IN 3491, and 10 mL IN 3496 for the humero-radial joint,
2 mL IV 3491 and 3496 for the coxi-femoral joint, and 2 mL IV
3496 for the femoro-tibial joint compared to other challenged
and control groups (p ＜ 0.05). Data for the control group are not
depicted due to the absence of detection for this bacterium.

Journal of Veterinary Science
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inoculation route.
M. hyosynoviae detection by qPCR
At least 30% of the joints tested positive for M. hyosynoviae
by qPCR at necropsy, regardless of the route of inoculation and
isolate used in the challenged groups. Approximately 60% of all
samples tested from two joints (humero-radial and coxi-femoral)
were qPCR positive when combining data from all routes of
inoculation for each isolate separately or together (Fig. 3). No
significant differences were found when comparing either the
proportion of M. hyosynoviae positive joints among anatomical
location were observed within each inoculated group, or in the
log10 bacterial load/2.5 L of sample among positive samples
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across groups (data not shown). Conversely, significant differences
in the proportion of M. hyosynoviae positive joints were found
when inoculated groups were compared within each anatomical
location. Specifically, a higher proportion of positive samples
was found for the following groups given in three joints: 5 mL
IN 3491, 10 mL IN 3491, and 10 mL IN 3496 for the humeroradial joint (p = 0.0238); 2 mL IV 3491 and 3496 for the
coxi-femoral joint (p = 0.025); and 2 mL IV 3496 for the
femoro-tibial joint (p = 0.0115) compared to other challenged
and control groups (Fig. 4). The tonsils of all inoculated animals
were consistently positive for M. hyosynoviae; however,
bacteremia was very rarely detected in whole blood or serum
(data not shown). All control animals were negative for M.

Fig. 5. Box-plot whiskers depicting the comparative analysis of M. hyosynoviae microscopic alterations by joint cavity. Histopathology
scores (ranging from minimum to maximum) are depicted across all panels. (A) Scapulo-humeral joints. (B) Humero-radial joints. (C)
Coxi-femoral joints. (D) Femoro-radial joints. (E) Tibio-tarsal joints. Statistical analysis was conducted by comparing all groups using
the non-parametric one-way ANOVA Kruskal-Wallis test followed by multiple comparisons with Dunn’s test. Different letters above
the box-plot whiskers data indicate significantly differences across groups (p ＜ 0.05).
www.vetsci.org
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Table 1. Odds ratio comparing diseased vs. non-diseased
animals based on the defined M. hyosynoviae- associated
disease diagnostic criteria

Joint cavity

Scapulo-humeral
Humero-radial
Coxi-femoral
Femoro-tibial
Tibio-tarsal

OR
Odds ratio 95% Confidence interval (CI)
(OR)*
Lower
Upper
5.2
2.4
4.2
1.0†
5.7

1.3
0.8
1.4
0.3†
1.6

20.4
7.0
12.1
2.7†
9.6

*Both qPCR and histopathological metrics were used as binary outcomes
(i.e., 0 or 1), as part of the diagnostic criteria used to predict clinical disease
post-exposure to M. hyosynoviae. The comparison was set to test the
effects of the impact of having M. hyosynoviae in the joint in addition to a
significantly altered microscopic score. OR and 95% CI are depicted for all
joint cavities assessed in the study. The OR threshold of significance is
equal to 1 since the presence of this value within the 95% CI indicates
absence of differences in the ratio between diseased and non-diseased
†
animals given the criterion of interest. These values in the table indicate
that both the humero-radial and femoro-tibial joints showed no significant
difference between the diseased and non-diseased animals.

hyosynoviae in the joint cavity, tonsils, blood, serum, and nasal
cavity. No other bacteria were found in the joints of inoculated
animals.
Histopathology
All challenge groups had at least one joint that was
significantly more affected than the control group. The
coxi-femoral joint was most consistently more affected in the
challenge group than the control group. Specifically, with the
exception of the group receiving 10 mL IN of 3496, all
challenged groups had significantly higher histopathological
alterations in the coxi-femoral joint than the non-challenge
group (Fig. 5). When combining the histopathological and
qPCR findings into a diagnostic metric, a significantly higher
likely of developing clinical disease vs. none was associated
with being qPCR positive and having histopathological lesions
in joints except for the femoro-tibial joint (Table 1).

Discussion
Mycoplasma hyosynoviae is one of the major causative
agents of arthritis in post-weaning pigs, particularly in
growing-finishing animals, along with M. hyorhinis, and other
bacteria such as Haemophilus parasuis, Streptococcus suis,
Erysipelothrix rhusiopathiae, and Salmonella enterica serovar
choleraesuis [4]. M. hyosynoviae induces a non-suppurative
self-limiting lameness in growing-finishing pigs [22]. Because
M. hyosynoviae-associated arthritis is considered a re-emerging
Journal of Veterinary Science

problem in swine production, particularly in the United States
[4], there is an increasing need to further investigate the
epidemiology and pathobiology of the disease associated with
it. While experimental induction of arthritis by this bacterium
has previously been described by both intranasal and
intramuscular inoculations [7,12,18], the present study was
conducted to compare the robustness of such an experimental
approach when varying the clinical isolate origin, route of
inoculation, and volume of inocula. Additionally, sampling of
multiple clinical specimens was conducted prior to and at
necropsy in attempt to propose an optimal diagnostic approach
for M. hyosynoviae detection and case confirmation. The
pathogen detection was then compiled with the histopathological
scoring to create a criterion to be used in defining the disease
status of an infected animal.
It is particularly important to mention that the use of
CDCD-SPF pigs ensured experimental success in this setting.
This approach prevented potential confounders such as the
presence of cross-reactive antibodies with other swine
mycoplasmas, as well as co-infections with other major swine
pathogens from impacting the study outcome [5]. As age had
been previously shown to not influence disease severity of M.
hyosynoviae-associated arthritis, six to twelve week-old
CDCD-SPF pigs were used in this study [12]. Following
inoculation, and irrespective of the isolate, route, and volume of
inocula, a high prevalence of animals tested positive for M.
hyosynoviae in the tonsil, but not in the nasal cavity. Although
this finding is not correlated with clinical outcome, it suggests
that the tonsil might be the primary reservoir for long-term
carriage [7,10,12]. Factors driving M. hyosynoviae tropism for
the tonsil rather than the nasal cavity are currently unknown
[1,11]. Given that long-term carriage in the tonsil is the likely
source of joint infection via septicemia within an animal, it is
possible that a source (tonsil)-and-sink (joint) infection
dynamic could explain the infection process [9,14]. Although
bacteremia was rarely in the whole blood or serum, as opposed
to in previous studies [7], the absence of the pathogen from
certain joints at necropsy supports this potential dynamic.
Specifically, disease re-occurrence within an animal, or joint
inflammation driven by this pathogen, would be dependent on
multiple joint invasions from organisms from the tonsil. Even
though this is an interesting association, it is yet to be
experimentally demonstrated. Nonetheless, it is important to
mention that, for epidemiological surveillance, tonsil sampling
may be more effective than nasal swabbing. These findings also
suggests that pen-based oral fluids can be effective in herd
screening [3].
The comparison between the two M. hyosynoviae clinical
isolates indicates that isolate 3491 is more virulent than 3496.
The IV route tends to induce clinical disease faster than IN for
both isolates, but to last for a shorter period than IN. That
distinctive pattern of IV vs IN may be explained by how fast the
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bacterial population can invade the joint tissue. However, the
fact that clinical diseases show a more rapid decrease in
prevalence and severity via the IV route than when using 10 mL
of inocula IN indicates that the resolution of the inflammatory
process is also more rapid for the former. This is an important
finding because there are advantages and disadvantages for both
routes of inoculation with respect to studying the pathogenesis of
this bacterium. In particular, if one is interested in reproducing
what is occurring in natural pig populations, the IN route would
be more suitable given that horizontal transmission is thought to
occur that way. However, depending on the isolate used, disease
may not occur in high frequency or severity. Conversely, by
inoculating via IV, the experimental approach may become
more robust and facilitate screening for isolates capable of
causing more severe disease since it bypasses the initial
colonization step of the upper respiratory tract. Yet, more
isolates would have to be tested to define the most optimal route
and volume of inocula and to determine the genotype-phenotype
correlation across M. hyosynoviae strains [7,13,22].
Although clear variations in distribution and severity of
clinical cases were seen between isolates, the histopathology
scores did not fully reflect these differences. This can be
partially attributed to the variability in timing of the necropsy
relative to the onset of clinical disease, in addition to the low or
absent bacterial load in joints at necropsy. Despite the lack of
specific joint tropism, the higher proportion of positivity, were
seen for the humero-radial, coxi-femoral, and scapula-humeral
joints. Combined, the qPCR and histopathological results
suggest that their uselfuness for post-mortem diagnostics only
comes when interpreted together as proposed in our diagnostic
criterion. As suggested here, a cohesive diagnosis of M.
hyosynoviae-associated arthritis should include the presence of
the bacterium and typical morphological alterations of the
synovia. In conclusion, this study demonstrated that clinical
lameness caused by M. hyosynoviae can be reproduced by
infecting CDCD pigs either IV or IN with no specific joint tissue
tropism. However, the variability in disease phenotype,
including pathogen detection and histopathological scoring,
strengthens the idea that post-mortem diagnostic criterion has to
be stringent to increase its accuracy. Moreover, given the
demonstration that differing clinical isolates can have a distinct
impact in clinical lameness, more comprehensives studies
should be conducted with well-established collections of
genotyped strains to determine the markers associated with
virulence of this pathogen.
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